Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients-Reference-Cited by-同舟云学术

Clinical significance of CD81 expression by clonal plasma cells in high-risk smoldering and symptomatic multiple myeloma patients

Published:2012-02-15 Issue:8 Volume:26 Page:1862-1869
ISSN:0887-6924
Container-title:Leukemia
language:en
Short-container-title:Leukemia

Author:

Paiva B, ,Gutiérrez N-C,Chen X,Vídriales M-B,Montalbán M-Á,Rosiñol L,Oriol A,Martínez-López J,Mateos M-V,López-Corral L,Díaz-Rodríguez E,Pérez J-J,Fernández-Redondo E,de Arriba F,Palomera L,Bengoechea E,Terol M-J,de Paz R,Martin A,Hernández J,Orfao A,Lahuerta J-J,Bladé J,Pandiella A,Miguel J-F San

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Cancer Research,Hematology

Link

http://www.nature.com/articles/leu201242.pdf

Reference40 articles.

1. Gutierrez NC, Castellanos MV, Martin ML, Mateos MV, Hernandez JM, Fernandez M et al. Prognostic and biological implications of genetic abnormalities in multiple myeloma undergoing autologous stem cell transplantation: t(4;14) is the most relevant adverse prognostic factor, whereas RB deletion as a unique abnormality is not associated with adverse prognosis. Leukemia 2007; 21: 143–150.

2. Gutierrez NC, Garcia JL, Hernandez JM, Lumbreras E, Castellanos M, Rasillo A et al. Prognostic and biologic significance of chromosomal imbalances assessed by comparative genomic hybridization in multiple myeloma. Blood 2004; 104: 2661–2666.

3. Avet-Loiseau H, Attal M, Moreau P, Charbonnel C, Garban F, Hulin C et al. Genetic abnormalities and survival in multiple myeloma: the experience of the Intergroupe Francophone du Myélome. Blood 2007; 109: 3489–3495.

4. Shaughnessy Jr JD, Zhan F, Burington BE, Huang Y, Colla S, Hanamura I et al. A validated gene expression model of high-risk multiple myeloma is defined by deregulated expression of genes mapping to chromosome 1. Blood 2007; 109: 2276–2284.

5. Mateo G, Montalban MA, Vidriales MB, Lahuerta JJ, Mateos MV, Gutierrez N et al. Prognostic value of immunophenotyping in multiple myeloma: a study by the PETHEMA/GEM cooperative study groups on patients uniformly treated with high-dose therapy. J Clin Oncol 2008; 26: 2737–2744.

Cited by 67 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Defining the Cell Surface Cysteinome Using Two-Step Enrichment Proteomics;JACS Au;2023-12-13

2. Immunophenotypic profile defines cytogenetic stability and unveils distinct prognoses in patients with newly-diagnosed multiple myeloma (NDMM);Annals of Hematology;2023-12-05

3. Defining the Cell Surface Cysteinome using Two-step Enrichment Proteomics;2023-10-19

4. Tetraspanin CD81 is expressed in human parotid cancer tissue and mediates cell proliferation;Journal of Oral and Maxillofacial Surgery, Medicine, and Pathology;2023-08

5. Recommendations for the study of monoclonal gammopathies in the clinical laboratory. A consensus of the Spanish Society of Laboratory Medicine and the Spanish Society of Hematology and Hemotherapy. Part I: update on laboratory tests for the study of monoclonal gammopathies;Clinical Chemistry and Laboratory Medicine (CCLM);2023-07-24